A Study to Test the Tolerability of an Investigational Electroporation Device in Healthy Adults (V930-001)
Probe Study of the Tolerability of an Investigational Electroporation Device, MedPulser (Trademark) DNA Delivery System (DDS) in Healthy Adults 18 to 35 Years of Age
2 other identifiers
interventional
24
0 countries
N/A
Brief Summary
A study to evaluate the tolerability of electrostimulation applications with an investigational device known as the MedPulser DDS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1 healthy
Started Jul 2005
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2005
CompletedFirst Submitted
Initial submission to the registry
July 22, 2008
CompletedFirst Posted
Study publicly available on registry
July 24, 2008
CompletedAugust 4, 2015
August 1, 2015
3 months
July 22, 2008
August 3, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assess the tolerability of the MedPulser DDS device.
Severity of pain will be measured at time of treatment and 1, 5, 10, and 20 minutes and 24 hours after electrostimulation.
Study Arms (1)
1
EXPERIMENTALV930
Interventions
Intramuscular injection of phosphate buffered saline solution will be given and within 2 - 5 minutes will be followed by an electrostimulation pulse with the MedPulser DDS in the deltoid muscle of the right arm. 15 days later, the same procedure will take place using the left arm.
Eligibility Criteria
You may qualify if:
- Must be between the ages of 18 and 35
- Woman who are able to become pregnant must use an acceptable form of birth control
You may not qualify if:
- You are breast feeding
- You have taken any type of pain reliever within 12 hours of electrostimulation
- You have participated in another clinical study within 4 weeks of starting this study or plan to participate in another clinical study while participating in this study
- You have muscle atrophy, weakness or neuromuscular disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Merck Sharp & Dohme LLClead
- University of California, San Diegocollaborator
- Inovio Pharmaceuticalscollaborator
Study Officials
- STUDY DIRECTOR
Medical Monitor
Merck Sharp & Dohme LLC
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 22, 2008
First Posted
July 24, 2008
Study Start
July 1, 2005
Primary Completion
October 1, 2005
Study Completion
October 1, 2005
Last Updated
August 4, 2015
Record last verified: 2015-08